Bristol-Myers Squibb Co.
NYSE:BMY 4:00:00 PM EDT
Products, Litigation
Cipla Ltd Says Settlement Of Revlimid (Lenalidomide) Capsules Patent Litigation
Published: 12/11/2020 14:36 GMT
Bristol-Myers Squibb Co. (BMY) - Cipla Ltd Says Announces Settlement of Revlimid® (lenalidomide) Capsules Patent Litigation.
Cipla Ltd - Celgene Agreed to Provide Co With License to Patents Needed to Make, Sell Some Volume-limited Amounts of Generic Lenalidomide in U.S.cipla - Ability to Market Lenalidomide in U.S. to Be Contingent on Obtaining Approval of Abbreviated New Drug Application.
Cipla Ltd - Celgene Agreed to Provide Co With License to Patents Needed to Make, Sell Some Volume-limited Amounts of Generic Lenalidomide in U.S.cipla - Ability to Market Lenalidomide in U.S. to Be Contingent on Obtaining Approval of Abbreviated New Drug Application.